Skip to content

Clinical trials

Lymphoma, T-Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20091
20113
20121
20131
20171
20183
20192
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4
Recruiting3
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Autolus Limited2
Seagen Inc.2
Acrotech Biopharma Inc.1
AstraZeneca1
BioInvent International AB1
Celgene1
Janssen Research & Development, LLC1
Mundipharma Research Limited1
Novartis Pharmaceuticals1
Prelude Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell18
Lymphoma9
Lymphoma, B-Cell4
Lymphoma, Large-Cell, Anaplastic4
Lymphoma, Non-Hodgkin4
Lymphoma, T-Cell, Peripheral4
Recurrence4
Lymphoproliferative Disorders3
Hematologic Diseases2
Immune System Diseases2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.